• Fatty Acid Profile, Peroxisomal
  • Cystic Fibrosis (CFTR) Gene Mutation Analysis
  • Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
  • Culture, Acid-Fast Bacilli, Urine
  • Clostridium difficile (C. Diff) by Molecular Method
  • CDKN1C Gene Mutation Analysis
  • Protriptyline, Urine
  • MSK-IMPACTâ„¢, Solid Organ Gene Cancer Panel
  • Fluconazole, Urine
  • B and T Cell Gene Rearrangement, Blood
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /MyProstateScore 2.0 (MPS2) for Prostate Cancer Early Detection
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

MyProstateScore 2.0 (MPS2) for Prostate Cancer Early Detection
Medical Test

Reference Ranges
Access to MyProstateScore 2.0 (MPS2) for Prostate Cancer Early Detection is restricted.